Arnold Library

AKT Modulates Sensitivity of AML Cells to Gemtuzumab Ozogamicin

Morris, Valerie (2013) AKT Modulates Sensitivity of AML Cells to Gemtuzumab Ozogamicin. Science Spotlight, 3 (3).

AKT Modulates Sensitivity of AML Cells to Gemtuzumab Ozogamicin.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (312Kb) | Preview
Article URL:
Item Type: Article
Additional Information: Rosen D.B., Harrington K.H., Cordeiro J.A., Leung L.Y., Putta S., Lacayo N., Laszlo G.S., Gudgeon C.J., Hogge D.E., Hawtin R.E., Cesano A., and Walter R.B. 2013. AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin. PLoS One 8:e53518 Also see: Walter R.B., Appelbaum F.R., Estey E.H., and Bernstein I.D. 2012. Acute myeloid leukemia stem cells and CD33-targeted immunotherapy. Blood 119:6198-208. Irish J.M., Kotecha N., Nolan G.P. 2006. Mapping normal and cancer cell signaling networks: towards single-cell proteomics. Nature Reviews Cancer 6:146-55.
Collections: Science Spotlight
Depositing User: Ben Abraham
Date Deposited: 19 Mar 2015 21:51
Last Modified: 19 Mar 2015 21:51

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy